This topic contains a solution. Click here to go to the answer

Author Question: Zajonc's model for how the presence of others influences individual performance is known as social ... (Read 66 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
Zajonc's model for how the presence of others influences individual performance is known as social facilitation. Facilitation refers to the fact that the presence of others facilitates a performer's
 
  a. ability to focus on the task at hand.
  b. task performance.
  c. evaluation apprehension.
  d. dominant response.

Question 2

Social psychologists reacted to critiques of the field in the 1960s and 1970s by doing all of the following except
 
  a. adopting more rigorous and formalized ethical standards.
  b. paying more attention to cross-cultural differences in cognition and behavior.
  c. denouncing experiments as unacceptably artificial.
  d. developing more stringent procedures to avoid the effects of experimenter bias.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janieazgirl

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

d

Answer to Question 2

c




Mr. Wonderful

  • Member
  • Posts: 866
Reply 2 on: Jun 22, 2018
:D TYSM


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

For a complete list of videos, visit our video library